0001793774-19-000002.txt : 20191119 0001793774-19-000002.hdr.sgml : 20191119 20191119111441 ACCESSION NUMBER: 0001793774-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191119 DATE AS OF CHANGE: 20191119 EFFECTIVENESS DATE: 20191119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEMPRIAN THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001793774 IRS NUMBER: 832994547 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-353694 FILM NUMBER: 191229555 BUSINESS ADDRESS: STREET 1: 2155 N BELL AVENUE CITY: CHICAGO STATE: IL ZIP: 60647 BUSINESS PHONE: 5133741180 MAIL ADDRESS: STREET 1: 2155 N BELL AVENUE CITY: CHICAGO STATE: IL ZIP: 60647 D 1 primary_doc.xml X0708 D LIVE 0001793774 TEMPRIAN THERAPEUTICS, INC. 2155 N BELL AVENUE CHICAGO IL ILLINOIS 60647 5133741180 DELAWARE None None Corporation true 2019 Kettil Cedercreutz 2155 N Bell Avenue Chicago IL ILLINOIS 60647 Executive Officer Director Isabelle Caroline Le Poole 2155 N Bell Avenue Chicago IL ILLINOIS 60647 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2019-01-25 false true true true Convertible Promissory Note false 0 325000 275000 50000 false 1 0 0 0 false TEMPRIAN THERAPEUTICS, INC. Kettil Cedercreutz Kettil Cedercreutz CEO 2019-11-19